Intra-Aortic Balloon Counterpulsation

Jeffrey C. Trost, L. David Hillis

Research output: Contribution to journalReview article

126 Scopus citations

Abstract

Intra-aortic balloon counterpulsation (IABP) is sometimes used in critically ill patients with cardiac disease. By increasing diastolic arterial pressure and decreasing systolic pressure, it reduces left ventricular afterload. IABP may be beneficial in subjects with cardiogenic shock, mechanical complications of myocardial infarction, intractable ventricular arrhythmias, or advanced heart failure or those who undergo "high-risk" surgical or percutaneous revascularization, but the evidence to support its use in these patient groups is largely observational. Contraindications to IABP include severe peripheral vascular disease as well as aortic regurgitation, dissection, or aneurysm. The potential benefits of IABP must be weighed against its possible complications (bleeding, systemic thromboembolism, limb ischemia, and, rarely, death).

Original languageEnglish (US)
Pages (from-to)1391-1398
Number of pages8
JournalAmerican Journal of Cardiology
Volume97
Issue number9
DOIs
StatePublished - May 1 2006

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Intra-Aortic Balloon Counterpulsation'. Together they form a unique fingerprint.

  • Cite this